Bridgeway Capital Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-88,893
| Closed | -$39.6K | – | 1206 |
|
|
2024
Q3 | $39.6K | Sell |
88,893
-62,180
| -41% | -$27.7K | ﹤0.01% | 1225 |
|
|
2024
Q2 | $400K | Sell |
151,073
-24,900
| -14% | -$66K | 0.01% | 912 |
|
|
2024
Q1 | $482K | Sell |
175,973
-36,100
| -17% | -$98.9K | 0.01% | 942 |
|
|
2023
Q4 | $515K | Buy |
212,073
+26,480
| +14% | +$64.3K | 0.01% | 935 |
|
|
2023
Q3 | $375K | Buy |
185,593
+42,193
| +29% | +$85.2K | 0.01% | 961 |
|
|
2023
Q2 | $423K | Buy |
143,400
+28,632
| +25% | +$84.5K | 0.01% | 953 |
|
|
2023
Q1 | $287K | Sell |
114,768
-93,432
| -45% | -$234K | 0.01% | 1021 |
|
|
2022
Q4 | $660K | Buy |
208,200
+98,100
| +89% | +$311K | 0.02% | 829 |
|
|
2022
Q3 | $327K | Buy |
+110,100
| New | +$327K | 0.01% | 1009 |
|